Evaluation of therapeutic use of a combination of pentoxifylline and vitamin E in radiation-induced renal fibrosis

Abstract Radiation-induced renal fibrosis (RIRF) is a progressive, irreversible condition causing chronic kidney disease. Pentoxifylline (PTX) and vitamin E may mitigate radiation-induced damage and fibrosis. This study assesses their effectiveness. We used four groups, each with six rats: radiation...

Full description

Bibliographic Details
Main Authors: Volkan Demircan, Caglar Guzel, Gulistan Sanem Sarıbas, Serap Catlı Dinc, Serhat Cetin, Ozlem Gulbahar, Petek Erpolat, Cigdem Elmas, Huseyin Bora
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-57850-0
_version_ 1827310303395708928
author Volkan Demircan
Caglar Guzel
Gulistan Sanem Sarıbas
Serap Catlı Dinc
Serhat Cetin
Ozlem Gulbahar
Petek Erpolat
Cigdem Elmas
Huseyin Bora
author_facet Volkan Demircan
Caglar Guzel
Gulistan Sanem Sarıbas
Serap Catlı Dinc
Serhat Cetin
Ozlem Gulbahar
Petek Erpolat
Cigdem Elmas
Huseyin Bora
author_sort Volkan Demircan
collection DOAJ
description Abstract Radiation-induced renal fibrosis (RIRF) is a progressive, irreversible condition causing chronic kidney disease. Pentoxifylline (PTX) and vitamin E may mitigate radiation-induced damage and fibrosis. This study assesses their effectiveness. We used four groups, each with six rats: radiation therapy alone (RT-only), radiation therapy plus drug treatment (RT + drug), drug treatment alone (drug-only), and a control group. Rats were monitored for three months, with weight measurements every four weeks. Afterward, rats were analyzed biochemically and histologically, with blood and tissue samples taken for statistical comparison. No significant differences in serum creatinine levels and body weight were observed. RT-only group had more severe kidney tubule effects. Histomorphological, immunohistochemical, and TUNEL analyses showed significant RIRF mitigation in the RT + drug group. Our study highlighted molecular pathways (SMAD, TGF-beta, VEGF) and histological markers (collagens, a-SMA, fibronectin, metalloproteinases) associated with RIRF. PTX and vitamin E reduced ionizing radiation's impact on renal cells and mitigated radiation-induced kidney fibrosis. Further human studies are needed to confirm these findings.
first_indexed 2024-04-24T19:58:39Z
format Article
id doaj.art-e26c2c76647e4dcebb1907f1a5e5d5be
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-24T19:58:39Z
publishDate 2024-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-e26c2c76647e4dcebb1907f1a5e5d5be2024-03-24T12:15:25ZengNature PortfolioScientific Reports2045-23222024-03-0114111410.1038/s41598-024-57850-0Evaluation of therapeutic use of a combination of pentoxifylline and vitamin E in radiation-induced renal fibrosisVolkan Demircan0Caglar Guzel1Gulistan Sanem Sarıbas2Serap Catlı Dinc3Serhat Cetin4Ozlem Gulbahar5Petek Erpolat6Cigdem Elmas7Huseyin Bora8Radiation Oncology Department, Acibadem Altunizade/Atasehir HospitalRadiation Oncology Department, Gazi University Medical FacultyHistology and Embryology Department, Health Sciences University Gulhane Medical FacultyRadiation Oncology Department, Gazi University Medical FacultyUrology Department, Gazi University Medical FacultyBiochemistry Department, Gazi University Medical FacultyRadiation Oncology Department, Gazi University Medical FacultyHistology Department, Gazi University Medical FacultyRadiation Oncology Department, Gazi University Medical FacultyAbstract Radiation-induced renal fibrosis (RIRF) is a progressive, irreversible condition causing chronic kidney disease. Pentoxifylline (PTX) and vitamin E may mitigate radiation-induced damage and fibrosis. This study assesses their effectiveness. We used four groups, each with six rats: radiation therapy alone (RT-only), radiation therapy plus drug treatment (RT + drug), drug treatment alone (drug-only), and a control group. Rats were monitored for three months, with weight measurements every four weeks. Afterward, rats were analyzed biochemically and histologically, with blood and tissue samples taken for statistical comparison. No significant differences in serum creatinine levels and body weight were observed. RT-only group had more severe kidney tubule effects. Histomorphological, immunohistochemical, and TUNEL analyses showed significant RIRF mitigation in the RT + drug group. Our study highlighted molecular pathways (SMAD, TGF-beta, VEGF) and histological markers (collagens, a-SMA, fibronectin, metalloproteinases) associated with RIRF. PTX and vitamin E reduced ionizing radiation's impact on renal cells and mitigated radiation-induced kidney fibrosis. Further human studies are needed to confirm these findings.https://doi.org/10.1038/s41598-024-57850-0
spellingShingle Volkan Demircan
Caglar Guzel
Gulistan Sanem Sarıbas
Serap Catlı Dinc
Serhat Cetin
Ozlem Gulbahar
Petek Erpolat
Cigdem Elmas
Huseyin Bora
Evaluation of therapeutic use of a combination of pentoxifylline and vitamin E in radiation-induced renal fibrosis
Scientific Reports
title Evaluation of therapeutic use of a combination of pentoxifylline and vitamin E in radiation-induced renal fibrosis
title_full Evaluation of therapeutic use of a combination of pentoxifylline and vitamin E in radiation-induced renal fibrosis
title_fullStr Evaluation of therapeutic use of a combination of pentoxifylline and vitamin E in radiation-induced renal fibrosis
title_full_unstemmed Evaluation of therapeutic use of a combination of pentoxifylline and vitamin E in radiation-induced renal fibrosis
title_short Evaluation of therapeutic use of a combination of pentoxifylline and vitamin E in radiation-induced renal fibrosis
title_sort evaluation of therapeutic use of a combination of pentoxifylline and vitamin e in radiation induced renal fibrosis
url https://doi.org/10.1038/s41598-024-57850-0
work_keys_str_mv AT volkandemircan evaluationoftherapeuticuseofacombinationofpentoxifyllineandvitamineinradiationinducedrenalfibrosis
AT caglarguzel evaluationoftherapeuticuseofacombinationofpentoxifyllineandvitamineinradiationinducedrenalfibrosis
AT gulistansanemsarıbas evaluationoftherapeuticuseofacombinationofpentoxifyllineandvitamineinradiationinducedrenalfibrosis
AT serapcatlıdinc evaluationoftherapeuticuseofacombinationofpentoxifyllineandvitamineinradiationinducedrenalfibrosis
AT serhatcetin evaluationoftherapeuticuseofacombinationofpentoxifyllineandvitamineinradiationinducedrenalfibrosis
AT ozlemgulbahar evaluationoftherapeuticuseofacombinationofpentoxifyllineandvitamineinradiationinducedrenalfibrosis
AT petekerpolat evaluationoftherapeuticuseofacombinationofpentoxifyllineandvitamineinradiationinducedrenalfibrosis
AT cigdemelmas evaluationoftherapeuticuseofacombinationofpentoxifyllineandvitamineinradiationinducedrenalfibrosis
AT huseyinbora evaluationoftherapeuticuseofacombinationofpentoxifyllineandvitamineinradiationinducedrenalfibrosis